Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-378
Agency: National Institutes of Health
Open Date: January 22, 2025
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.273, 93.213, 93.313, 93.866, 93.279, 93.310, 93.865, 93.361, 93.113, 93.121, 93.242
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
Deadline: March 8, 2026
Opportunity Number: RFA-DK-26-007
Agency: National Institutes of Health
Open Date: January 15, 2025
Close Date: March 8, 2026
Status: Posted
CFDA Numbers: 93.847
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-352
Agency: National Institutes of Health
Open Date: January 15, 2025
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.242
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-353
Agency: National Institutes of Health
Open Date: January 15, 2025
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.242
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
Deadline: October 14, 2027
Opportunity Number: PAR-25-313
Agency: National Institutes of Health
Open Date: January 14, 2025
Close Date: October 14, 2027
Status: Posted
CFDA Numbers: 93.398
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Deadline: November 18, 2026
Opportunity Number: PAR-25-369
Agency: National Institutes of Health
Open Date: January 13, 2025
Close Date: November 18, 2026
Status: Posted
CFDA Numbers: 93.313, 93.279, 93.310, 93.399, 93.172, 93.865, 93.867, 93.855, 93.173, 93.121, 93.113, 93.242, 93.989, 93.853
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Deadline: November 18, 2026
Opportunity Number: PAR-25-371
Agency: National Institutes of Health
Open Date: January 13, 2025
Close Date: November 18, 2026
Status: Posted
CFDA Numbers: 93.313, 93.307, 93.310, 93.399, 93.173, 93.865, 93.867, 93.855, 93.242, 93.172, 93.113, 93.279, 93.853
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Deadline: November 16, 2026
Opportunity Number: PAR-25-370
Agency: National Institutes of Health
Open Date: January 13, 2025
Close Date: November 16, 2026
Status: Posted
CFDA Numbers: 93.313, 93.173, 93.121, 93.279, 93.310, 93.113, 93.399, 93.172, 93.989, 93.242, 93.855, 93.865
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
Deadline: May 7, 2027
Opportunity Number: PAR-25-342
Agency: National Institutes of Health
Open Date: January 13, 2025
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.313, 93.307, 93.361
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-091
Agency: National Institutes of Health
Open Date: January 10, 2025
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.847
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-358
Agency: National Institutes of Health
Open Date: January 10, 2025
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.867
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-319
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.173
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-318
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.173
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAR-24-329
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.279
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PA-25-150
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853, 93.242
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
Deadline: January 7, 2028
Opportunity Number: PAR-25-250
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.173
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-068
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.847
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAS-25-073
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.847
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAS-25-102
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.847
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PA-25-169
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.867, 93.286, 93.866
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-377
Agency: National Institutes of Health
Open Date: January 8, 2025
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.121, 93.313, 93.361, 93.866, 93.393, 93.307
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
Deadline: October 1, 2026
Opportunity Number: RFA-DC-25-003
Agency: National Institutes of Health
Open Date: January 6, 2025
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 93.173
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
Deadline: October 1, 2026
Opportunity Number: RFA-DC-25-005
Agency: National Institutes of Health
Open Date: January 6, 2025
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 93.173
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
Deadline: September 7, 2028
Opportunity Number: PAR-25-324
Agency: National Institutes of Health
Open Date: January 6, 2025
Close Date: September 7, 2028
Status: Posted
CFDA Numbers: 93.393, 93.396, 93.395, 93.399, 93.394, 93.397
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
Deadline: October 18, 2027
Opportunity Number: PAR-25-343
Agency: National Institutes of Health
Open Date: January 6, 2025
Close Date: October 18, 2027
Status: Posted
CFDA Numbers: 93.173